vs
Side-by-side financial comparison of CIVISTA BANCSHARES, INC. (CIVB) and Evolus, Inc. (EOLS). Click either name above to swap in a different company.
Evolus, Inc. is the larger business by last-quarter revenue ($73.1M vs $47.3M, roughly 1.5× CIVISTA BANCSHARES, INC.). CIVISTA BANCSHARES, INC. runs the higher net margin — 31.7% vs -14.6%, a 46.3% gap on every dollar of revenue. Over the past eight quarters, CIVISTA BANCSHARES, INC.'s revenue compounded faster (11.3% CAGR vs 4.6%).
Civista Bancshares, Inc. is a US-based bank holding company operating primarily across the Midwest region. It provides a full suite of personal and commercial banking services including deposit accounts, mortgage, consumer and commercial lending products, as well as wealth management solutions, serving retail consumers, small and medium-sized local businesses and community client segments.
Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.
CIVB vs EOLS — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $47.3M | $73.1M |
| Net Profit | $15.0M | $-10.7M |
| Gross Margin | — | 66.9% |
| Operating Margin | — | 23.8% |
| Net Margin | 31.7% | -14.6% |
| Revenue YoY | — | 6.7% |
| Net Profit YoY | 47.4% | — |
| EPS (diluted) | $0.72 | $-0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $47.3M | $73.1M | ||
| Q4 25 | $46.3M | $90.3M | ||
| Q3 25 | $44.2M | $69.0M | ||
| Q2 25 | $41.4M | $69.4M | ||
| Q1 25 | $40.6M | $68.5M | ||
| Q4 24 | $40.4M | $78.9M | ||
| Q3 24 | $39.3M | $61.1M | ||
| Q2 24 | $38.1M | $66.9M |
| Q1 26 | $15.0M | $-10.7M | ||
| Q4 25 | — | $130.0K | ||
| Q3 25 | $12.8M | $-15.7M | ||
| Q2 25 | $11.0M | $-17.1M | ||
| Q1 25 | $10.2M | $-18.9M | ||
| Q4 24 | — | $-6.8M | ||
| Q3 24 | $8.4M | $-19.2M | ||
| Q2 24 | $7.1M | $-11.3M |
| Q1 26 | — | 66.9% | ||
| Q4 25 | — | 65.7% | ||
| Q3 25 | — | 66.5% | ||
| Q2 25 | — | 65.3% | ||
| Q1 25 | — | 68.1% | ||
| Q4 24 | — | 66.7% | ||
| Q3 24 | — | 68.9% | ||
| Q2 24 | — | 70.3% |
| Q1 26 | — | 23.8% | ||
| Q4 25 | 31.8% | 4.7% | ||
| Q3 25 | 35.4% | -16.7% | ||
| Q2 25 | 31.1% | -14.7% | ||
| Q1 25 | 29.4% | -22.1% | ||
| Q4 24 | 28.2% | -2.9% | ||
| Q3 24 | 25.2% | -25.3% | ||
| Q2 24 | 21.2% | -11.5% |
| Q1 26 | 31.7% | -14.6% | ||
| Q4 25 | — | 0.1% | ||
| Q3 25 | 28.9% | -22.8% | ||
| Q2 25 | 26.6% | -24.7% | ||
| Q1 25 | 25.0% | -27.6% | ||
| Q4 24 | — | -8.6% | ||
| Q3 24 | 21.3% | -31.4% | ||
| Q2 24 | 18.5% | -17.0% |
| Q1 26 | $0.72 | $-0.16 | ||
| Q4 25 | $0.59 | $0.01 | ||
| Q3 25 | $0.68 | $-0.24 | ||
| Q2 25 | $0.71 | $-0.27 | ||
| Q1 25 | $0.66 | $-0.30 | ||
| Q4 24 | $0.62 | $-0.11 | ||
| Q3 24 | $0.53 | $-0.30 | ||
| Q2 24 | $0.45 | $-0.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $49.8M |
| Total DebtLower is stronger | — | $156.4M |
| Stockholders' EquityBook value | $553.9M | — |
| Total Assets | $4.3B | $220.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $49.8M | ||
| Q4 25 | — | $53.8M | ||
| Q3 25 | — | $43.5M | ||
| Q2 25 | — | $61.7M | ||
| Q1 25 | — | $67.9M | ||
| Q4 24 | — | $87.0M | ||
| Q3 24 | — | $85.0M | ||
| Q2 24 | — | $93.7M |
| Q1 26 | — | $156.4M | ||
| Q4 25 | — | $146.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $121.8M | ||
| Q4 24 | — | $121.5M | ||
| Q3 24 | — | $121.2M | ||
| Q2 24 | — | $120.9M |
| Q1 26 | $553.9M | — | ||
| Q4 25 | $543.5M | $-23.1M | ||
| Q3 25 | $499.0M | $-28.8M | ||
| Q2 25 | $404.1M | $-18.7M | ||
| Q1 25 | $397.4M | $-6.6M | ||
| Q4 24 | $388.5M | $5.5M | ||
| Q3 24 | $394.4M | $5.9M | ||
| Q2 24 | $373.8M | $19.3M |
| Q1 26 | $4.3B | $220.6M | ||
| Q4 25 | $4.3B | $225.9M | ||
| Q3 25 | $4.1B | $219.0M | ||
| Q2 25 | $4.2B | $228.8M | ||
| Q1 25 | $4.1B | $213.4M | ||
| Q4 24 | $4.1B | $232.6M | ||
| Q3 24 | $4.1B | $229.6M | ||
| Q2 24 | $4.0B | $233.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 22.00× | ||
| Q3 24 | — | 20.58× | ||
| Q2 24 | — | 6.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CIVB
| Net Interest Income | $37.8M | 80% |
| Noninterest Income | $9.4M | 20% |
EOLS
| Product revenue, net | $72.7M | 99% |
| Service revenue | $390.0K | 1% |
